Pro Medicus Ltd banner

Pro Medicus Ltd
ASX:PME

Watchlist Manager
Pro Medicus Ltd Logo
Pro Medicus Ltd
ASX:PME
Watchlist
Price: 165.64 AUD 4.03% Market Closed
Market Cap: AU$17.3B

Wall St Price Targets

PME Price Targets Summary
Pro Medicus Ltd

Wall Street analysts forecast PME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PME is 205.18 AUD with a low forecast of 146.48 AUD and a high forecast of 259.35 AUD.

Lowest Forecast
Price Target
146.48 AUD
12% Downside
Average Forecast
Price Target
205.18 AUD
24% Upside
Highest Forecast
Price Target
259.35 AUD
57% Upside
Pro Medicus Ltd Competitors:
Price Targets
BBW
Build-A-Bear Workshop Inc
86% Upside
MGNX
MacroGenics Inc
57% Upside
CORE
Allcore SpA
156% Upside

Revenue
Forecast

26% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
26% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 8 years is 16%.

Gross Profit
Forecast

26% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
26% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Pro Medicus Ltd

Operating Income
Forecast

67% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
67% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 13 years, the compound annual growth rate for Operating Income has been 67%. The projected CAGR for the next 8 years is 12%.

Pre-Tax Income
Forecast

48% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
48% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Pro Medicus Ltd

Net Income
Forecast

38% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
38% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 38%. The projected CAGR for the next 8 years is 18%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PME's stock price target?
Price Target
205.18 AUD

According to Wall Street analysts, the average 1-year price target for PME is 205.18 AUD with a low forecast of 146.48 AUD and a high forecast of 259.35 AUD.

What is the Revenue forecast for Pro Medicus Ltd?
Projected CAGR
16%

Over the last 13 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 8 years is 16%.

What is the Operating Income forecast for Pro Medicus Ltd?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Operating Income has been 67%. The projected CAGR for the next 8 years is 12%.

What is the Net Income forecast for Pro Medicus Ltd?
Projected CAGR
18%

Over the last 13 years, the compound annual growth rate for Net Income has been 38%. The projected CAGR for the next 8 years is 18%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett